CNS

CNS refers to central nervous system diseases such as depression, schizophrenia, epilepsy, Alzheimer's disease, Parkinson's disease, and other neurological or psychiatric conditions. Companies on this page are grouped by their exposure to brain and nervous system therapeutics.

Why watch CNS

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest CNS news

The latest feed items from companies currently grouped under CNS.

1. 01
   2026-09-09 12:30 EST

   XERSXeris Hosts Webinar Detailing Its Comprehensive Development Program for XP-8121, an Investigational, Once-Weekly Subcutaneous Levothyroxine for Hypothyroidism

   Source: Xeris Pharmaceuticals

2. 02
   2026-09-09 12:00 EST

   ECORelectroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

   Source: electroCore

3. 03
   2026-09-09 11:30 EST

   NGENNervGen to Host Inaugural R&D Day on September 30, 2026

   Source: NervGen Pharma

4. 04
   2026-09-08 11:30 EST

   CGTXCognition Therapeutics to Present at H.C. Wainwright Global Investment Conference

   Source: Cognition Therapeutics

5. 05
   2026-09-08 11:00 EST

   ANLAdlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC

   Source: Adlai Nortye Ltd.

6. 06
   2026-09-08 11:00 EST

   TNXPTonix Pharmaceuticals Promotes Thomas Englese, MBA, to Chief Commercial Officer

   Source: Tonix Pharmaceuticals

7. 07
   2026-09-08 10:00 EST

   MNOVMediciNova to Participate in Two Investor Conferences in September

   Source: MediciNova

8. 08
   2026-09-07 07:53 EST

   TEVATeva Announces Launch of Offering of Senior Notes

   Source: Teva Pharmaceutical Industries

9. 09
   2026-09-04 15:30 EST

   TEVAS&P Global Ratings Upgrades Teva to BBB-, Marking Third Credit Rating Upgrade in Recent Months and Reflecting Strong Execution and Financial Discipline

   Source: Teva Pharmaceutical Industries

10. 10
    2026-09-04 12:00 EST

    TSHATaysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

    Source: Taysha Gene Therapies

11. 11
    2026-09-03 23:30 EST

    BIIBStoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC)

    Source: Biogen

12. 12
    2026-09-03 20:05 EST

    KTTAPasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences

    Source: Pasithea Therapeutics

13. 13
    2026-09-03 20:01 EST

    XENEXenon to Present at Wells Fargo Healthcare Conference

    Source: Xenon

14. 14
    2026-09-03 20:01 EST

    PRAXPraxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Source: Praxis Precision Medicines

15. 15
    2026-09-03 12:05 EST

    HRMYHarmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress

    Source: Harmony Biosciences

16. 16
    2026-09-03 12:00 EST

    OVIDOvid Therapeutics to Participate in Upcoming Investor Conferences

    Source: Ovid Therapeutics

17. 17
    2026-09-03 12:00 EST

    CLNNClene to Present at Upcoming September Investor Conferences

    Source: Clene Inc.

18. 18
    2026-09-03 11:05 EST

    ATHEAlterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026

    Source: Alterity Therapeutics

19. 19
    2026-09-03 04:00 EST

    BIIBLEQEMBI® (lecanemab) Subcutaneous Formulation as an Initiation Treatment for Early Alzheimer’s Disease Approved in China

    Source: Biogen

20. 20
    2026-09-02 20:30 EST

    SUPNSupernus Pharmaceuticals to Participate in September Investor Conferences

    Source: Supernus

Companies in CNS

92 companies tagged with CNS.

Frequently Asked Questions